Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 3
Subtitle 10 - LABORATORIES
Chapter 10.10.13 - Medical Laboratories - Testing for Hereditary and Congenital Disorders in Newborn Infants
Section 10.10.13.17 - Testing - First-Tier

Universal Citation: MD Code Reg 10.10.13.17

Current through Register Vol. 51, No. 19, September 20, 2024

A. The Department's public health laboratory shall test, using first-tier tests, appropriately timed and collected blood-spot specimen of a newborn infant's blood for the disorders listed in Regulation .12C of this chapter.

B. Full-Term Healthy Newborn Infants.

(1) If a newborn infant is born at term and is healthy, the Department's public health laboratory shall conduct a:
(a) First screening using first-tier tests to detect the disorders listed in Regulation .12C of this chapter on a blood-spot specimen collected when the full-term healthy newborn infant is between 24 and 48 hours old; and

(b) Second screening using first-tier tests on a blood-spot specimen collected when the full-term healthy infant is between 10 and 14 days old.

(2) If the first blood-spot specimen is collected when a full term healthy newborn infant is younger than 24 hours old, the Department's public health laboratory shall conduct a:
(a) Second screening using first-tier tests to detect the disorders listed in Regulation .12C of this chapter on a blood-spot specimen collected when the newborn infant is between 24 hours and 7 days old; and

(b) Third screening using first-tier tests on a blood-spot specimen collected when the full-term healthy infant is between 1 and 4 weeks old.

C. Premature or 111 Newborn Infant.

(1) If a newborn infant who is born prematurely or expected to be ill for more than 14 days was younger than 24 hours old when the blood-spot specimen was collected for a first screening, the Department's public health laboratory shall conduct a:
(a) Second screening using first-tier tests to detect the disorders listed in Regulation .12C of this chapter when the newborn infant is between 24 hours and 3 days old; and

(b) Third screening using first-tier tests when the newborn infant is between 7 days and 14 days old to screen for:
(i) Amino acid disorders as specified in Regulation .12C(11)-(24) of this chapter;

(ii) Acylcarnitine disorders as specified in Regulation .12C(25)-(52) of this chapter;

(iii) Congenital hypothyroidism as specified in Regulation .12C(4) of this chapter ; and

(iv) Severe combined immunodeficiency, as specified in Regulation .12C(54) of this chapter.

(2)If a newborn infant who is born prematurely or expected to be ill for more than 14 days was 24 hours old or older at the time the newborn infant's blood-spot specimen was collected for a first screening, the Department's public health laboratory shall perform a second screening to screen for:
(a) Amino acid disorders as specified in Regulation .12C(11)-(24) of this chapter;

(b) Acylcarnitine disorders as specified in Regulation .12C(25)-(52) of this chapter;

(c) Congenital hypothyroidism as specified in Regulation .12C(4) of this chapter ; and

(d) Severe combined immunodeficiency, as specified in Regulation .12C(54) of this chapter.

(3) If a newborn infant was transfused before the blood-spot specimen was collected for a first screening, the Department's public health laboratory shall conduct, in addition to any other screenings specified in §B(1) and (2) of this regulation, a fourth screening using first-tier tests on a blood-spot specimen collected 4 months after a newborn infant's last transfusion to screen for:
(a) Hemoglobin as specified in Regulation .12C(7)-(10) of this chapter;

(b) Biotinidase as specified in Regulation .12C(1) of this chapter; and

(c) Galactose-1-P-uridyl-1-transferase as specified in Regulation .12C(3) of this chapter.

Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.